1. Home
  2. EXEL vs LSCC Comparison

EXEL vs LSCC Comparison

Compare EXEL & LSCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • LSCC
  • Stock Information
  • Founded
  • EXEL 1994
  • LSCC 1983
  • Country
  • EXEL United States
  • LSCC United States
  • Employees
  • EXEL N/A
  • LSCC N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • LSCC Semiconductors
  • Sector
  • EXEL Health Care
  • LSCC Technology
  • Exchange
  • EXEL Nasdaq
  • LSCC Nasdaq
  • Market Cap
  • EXEL 10.4B
  • LSCC 8.8B
  • IPO Year
  • EXEL 2000
  • LSCC 1989
  • Fundamental
  • Price
  • EXEL $40.35
  • LSCC $71.29
  • Analyst Decision
  • EXEL Buy
  • LSCC Strong Buy
  • Analyst Count
  • EXEL 22
  • LSCC 10
  • Target Price
  • EXEL $44.00
  • LSCC $66.10
  • AVG Volume (30 Days)
  • EXEL 2.3M
  • LSCC 2.1M
  • Earning Date
  • EXEL 10-28-2025
  • LSCC 11-03-2025
  • Dividend Yield
  • EXEL N/A
  • LSCC N/A
  • EPS Growth
  • EXEL 81.76
  • LSCC N/A
  • EPS
  • EXEL 2.08
  • LSCC 0.23
  • Revenue
  • EXEL $2,230,005,000.00
  • LSCC $488,631,000.00
  • Revenue This Year
  • EXEL $9.19
  • LSCC $3.92
  • Revenue Next Year
  • EXEL $12.54
  • LSCC $19.45
  • P/E Ratio
  • EXEL $19.56
  • LSCC $289.22
  • Revenue Growth
  • EXEL 10.73
  • LSCC N/A
  • 52 Week Low
  • EXEL $25.17
  • LSCC $34.69
  • 52 Week High
  • EXEL $49.62
  • LSCC $70.55
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 61.73
  • LSCC 74.75
  • Support Level
  • EXEL $38.37
  • LSCC $64.02
  • Resistance Level
  • EXEL $40.78
  • LSCC $66.35
  • Average True Range (ATR)
  • EXEL 1.01
  • LSCC 2.26
  • MACD
  • EXEL 0.41
  • LSCC -0.09
  • Stochastic Oscillator
  • EXEL 91.21
  • LSCC 94.75

About EXEL Exelixis Inc.

Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

Share on Social Networks: